Efficacy and safety of a basal insulin + 2‐3 oral antihyperglycaemic drugs regimen versus a twice‐daily premixed insulin + metformin regimen after short‐term intensive insulin therapy in individuals with type 2 diabetes: The multicentre, open‐label, randomized controlled <scp>BEYOND‐V</scp> trial
Diabetes Obesity and Metabolism2022cited by 4position: middledoi